Lax and corrupt – Indian Dr assesses clinical trials

By Nick Taylor

- Last updated on GMT

Related tags: Clinical trials, India

An Indian doctor has slammed the nation’s clinical trials, claiming they use the vulnerable, the system is corrupt and that the country lacks high quality scientists.

The criticisms were made by Dr Amar Jesani in a short-film produced by Dutch non-governmental organisation Wemos. Jesani is a founding member of journals and research centres focused on medical ethics in India and has contributed in government committees on health.

India’s clinical trials came under increasing pressure last year following reports of infant deaths and Jesani’s comments show that some are still deeply uneasy about the current system.

The view held by Jesani, which echoes many who spoke out last year about the infant deaths, is that some drug companies are “compromising science and ethics in the pursuit of profit​” and that flaws in the Indian system allow this.

Jesani said: “Unfortunately in my country there are laws but they are not very well implemented so the regulation over the trials, the oversight mechanism, the functioning of the ethics committee and the Drug Controller General of India all of them are so lax that it makes India a big destination for clinical trials​.

They don’t have good scientists; they don’t have enough inspectors to go all over the county. The worst thing in every developing country is corruption. There is too much corruption​.”

One consequence of this is that clinical trials use the “desperate​” and “most vulnerable​” members if Indian society, according to Jesani. This alleged exploitation of India’s poor is what Jesani cites as bothering him most about the current system.

Jesani is a founder member of the Indian Journal of Medical Ethics (IJME), the Centre for Studies in Ethics and Rights (CSER) and the Centre for Enquiry into Health and Allied Themes (CEHAT).

The short-film can be viewed here​.

Related news

Show more

Related products

show more

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Related suppliers

Follow us

Products

View more

Webinars